Sign in
Taking people in United StatesPhase 2

Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 2

Key facts

Who runs it
Yale University
Where
West Haven, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
36 people, planned
Started
1 Sept 2026
Expected to end
31 Dec 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Bupivacaine bilateral greater occipital nerve block
Record updated
8 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • United States Military Veterans within VA Connecticut Healthcare System1
  • Head injury with headaches that have continued to occur for at least three months after the head injury
  • At least two headache days per week
  • Review of the medical record does not reveal another source for headache

Who cannot take part

  • Allergy or adverse reaction (e.g., rash, cardiac effects) to amide anesthetics, such as lidocaine
  • Skull defect
  • Other contraindication to bupivacaine
  • Instruction from clinician to avoid amide anesthetics, such as lidocaine
  • Pregnant or lack of adequate birth control
  • Clinical review of the patient's case reveals red flag signs or symptoms (e.g., side-locked pain, unilateral numbness/weakness during headache, rapid ascension to peak pain, syncope during attacks) that warrant further work-up (e.g., MRI, arterial imaging)
  • Absence of imaging warranted by the standard of clinical care for the head injury with headaches

This trial is currently available in United States.

  • VA Connecticut Healthcare SystemWest Haven, United StatesContact: Emmanuelle Schindler, MD, PhDTaking people

About the trial

What the trial wants to find out

Anesthetic greater occipital nerve (GON) blockade is a simple, inexpensive, and safe procedure that has demonstrable headache pain suppressing effects. In this study, Veterans with post-traumatic headache will be randomized to receive 0.0%, 0.05%, or 0.5% bupivacaine in bilateral GON blocks and the lasting (i.e., transitional) effects on headache frequency measured in a headache diary.

The 3 groups in the trial

  • PlaceboPlacebo, for comparison

    0.0% bupivacaine (normal saline)

    Treatment: Bupivacaine bilateral greater occipital nerve block

  • Low dose bupivacaineExisting treatment, for comparison

    0.05% bupivacaine

    Treatment: Bupivacaine bilateral greater occipital nerve block

  • Full dose bupivacaineTreatment being tested

    0.5% bupivacaine

    Treatment: Bupivacaine bilateral greater occipital nerve block

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Anesthetic Greater Occipital Nerve Blockade in Veterans With Post-Traumatic Headache: Sub-study 2
Record updated
8 September 2026